Neuroendocrine tumor treatment | Patent Number 09006224

US 09006224 B2
Application Number12094173
Publication NumberUS 20080255029 A1
Pendency8 years, 4 months, 27 days
Filled DateNov 20, 2006
Priority DateNov 20, 2006
Publication DateOct 16, 2008
Expiration DateNov 19, 2026
Inventor/ApplicantsDavid Lebwohl
Peter Wayne Marks
ExaminesJEAN-LOUIS, SAMIRA JM
Art Unit1627
Technology Center1600
Assignments
Novartis
Current
Novartis
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.